- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/46 - 8-Azabicyclo [3.2.1] octaneDerivatives thereof, e.g. atropine, cocaine
Patent holdings for IPC class A61K 31/46
Total number of patents in this class: 1166
10-year publication summary
|
119
|
88
|
107
|
109
|
118
|
107
|
77
|
73
|
48
|
28
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10338 |
32 |
| Sydnexis, Inc. | 54 |
29 |
| Theravance Biopharma R&D IP, LLC | 416 |
24 |
| Saniona A/S | 50 |
21 |
| Vyluma Inc. | 34 |
19 |
| Boehringer Ingelheim International GmbH | 4494 |
18 |
| Noden Pharma Designated Activity Company | 16 |
15 |
| The Regents of the University of California | 20590 |
13 |
| Incelldx, Inc. | 48 |
13 |
| Neurosearch A/S | 148 |
13 |
| Cipla Limited | 472 |
12 |
| Initiator Pharma A/S | 22 |
11 |
| Merck Sharp & Dohme LLC | 3737 |
10 |
| DexCom, Inc. | 1717 |
9 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 861 |
9 |
| Taisho Pharmaceutical Co., Ltd. | 855 |
9 |
| University of Manitoba | 441 |
9 |
| ACADIA Pharmaceuticals Inc. | 194 |
8 |
| Almirall, S.A. | 488 |
8 |
| Janssen Biotech, Inc. | 1738 |
8 |
| Other owners | 876 |